[Efficacy of sucralfate in the prevention of stomach diseases induced by non-steroidal anti-inflammatory drugs].
In 20 patients suffering from osteoarthritis and treated with non steroidal anti-inflammatory drugs (NSAIDs) for one month sucralfate has been added for further two months. Endoscopic examination before/after this treatment confirmed the cytoprotective property of sucralfate, with normalization of the gastric mucosa and subsidence of subjective symptomatology.
Fioravanti
A
A
Giordano
N
N
Biasi
G
G
Vaccai
D
D
Cataldi
V
V
Marcolongo
R
R
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D004008:Diclofenac / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000008:administration & dosage; D010003:Osteoarthritis / Q000188:drug therapy; D010894:Piroxicam / Q000008:administration & dosage; D013272:Stomach Diseases / Q000139:chemically induced* / Q000517:prevention & control; D013392:Sucralfate / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; D004008:Diclofenac; D013392:Sucralfate; D009288:Naproxen
Efficacia del sucralfato nella profilassi delle gastropatie indotte dai farmaci antiinfiammatori non steroidei.